Prostate cancer Trials in Padua, Italy
Conditions / Prostate cancer / Padua, Italy
Prostate cancer is a medical condition with active clinical research programs worldwide.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01794793 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | COMPLETED | PHASE4 |
| NCT02785887 | Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients | COMPLETED | NA |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT01444456 | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | COMPLETED | — |
| NCT01605227 | Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 | COMPLETED | PHASE3 |
| NCT02003924 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | COMPLETED | PHASE3 |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | COMPLETED | PHASE3 |
| NCT04644068 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT03840200 | A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. | COMPLETED | PHASE1 |